White Martha V, Hogue Susan L, Odom Dawn, Cooney Darryl, Bartsch Jennifer, Goss Diana, Hollis Kelly, Herrem Christopher, Silvia Suyapa
Institute for Asthma and Allergy , Wheaton, Maryland.
RTI International , Research Triangle Park, North Carolina.
Pediatr Allergy Immunol Pulmonol. 2016 Sep 1;29(3):149-154. doi: 10.1089/ped.2016.0675.
A pilot survey described the characteristics of anaphylactic events occurring in an initial set of participating U.S. schools during the 2013-2014 school year. This survey was subsequently readministered to large school districts, which were underrepresented in initial results. A cross-sectional survey was administered to the U.S. schools that were participating in the EPIPEN4SCHOOLS program (Mylan Specialty L.P., Canonsburg, PA) to assess characteristics of anaphylactic events. Data from large school districts were added to initial findings in this comprehensive combined analysis. A total of 1,140 anaphylactic events were reported among 6,574 responding schools. Of 1,063 anaphylactic events with data on who experienced the event, it was observed that it occurred mostly in students (89.5%, 951/1,063). For students, anaphylactic events were reported across all grades, with 44.9% (400/891) occurring in high school students, 18.9% (168/891) in middle school students, and 32.5% (290/891) in elementary school students. Food was identified as the most common trigger (60.1%, 622/1,035). A majority of schools (55.0%, 3,332/6,053) permitted only the school nurse and select staff to administer epinephrine to treat anaphylaxis. The unpredictability of anaphylaxis is emphasized by its high occurrence in individuals with no known allergies (25.0%). A majority of schools permitted only the school nurse and select staff to treat anaphylaxis. Thus, individuals experiencing an anaphylactic event may frequently encounter staff members not being permitted to administer potentially life-saving epinephrine. Epinephrine auto-injectors provided by the EPIPEN4SCHOOLS program were used to treat 38.0% of events. Anaphylaxis can occur in children with no previously known allergies, illustrating the importance of public access to epinephrine.
一项初步调查描述了2013 - 2014学年美国首批参与学校中发生的过敏反应事件的特征。随后,该调查重新施测于在初步结果中代表性不足的大型学区。对参与“EPIPEN4SCHOOLS”项目(迈兰特殊药品有限责任公司,宾夕法尼亚州卡农斯堡)的美国学校进行了横断面调查,以评估过敏反应事件的特征。在这项全面的综合分析中,将来自大型学区的数据添加到了初步调查结果中。在6574所回复的学校中,共报告了1140起过敏反应事件。在1063起有经历该事件人员数据的过敏反应事件中,观察到该事件大多发生在学生中(89.5%,951/1063)。对于学生而言,各年级均有过敏反应事件报告,其中高中生中发生的比例为44.9%(400/891),初中生中为18.9%(168/891),小学生中为32.5%(290/891)。食物被确定为最常见的诱因(60.1%,622/1035)。大多数学校(55.0%,3332/6053)只允许学校护士和特定工作人员使用肾上腺素治疗过敏反应。过敏反应在无已知过敏史的个体中高发(25.0%),这凸显了其不可预测性。大多数学校只允许学校护士和特定工作人员治疗过敏反应。因此,经历过敏反应事件的个体可能经常遇到工作人员不被允许使用可能挽救生命的肾上腺素的情况。“EPIPEN4SCHOOLS”项目提供的肾上腺素自动注射器用于治疗38.0%的事件。过敏反应可发生在先前无已知过敏史的儿童中,这说明了公众能够获取肾上腺素的重要性。